...
首页> 外文期刊>Journal of cardiovascular magnetic resonance : >The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease
【24h】

The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease

机译:多巴酚丁胺应激心血管磁共振在可疑和已知冠状动脉疾病患者临床管理中的作用

获取原文
           

摘要

BackgroundRecent studies have demonstrated the consistently high diagnostic and prognostic value of dobutamine stress cardiovascular magnetic resonance (DCMR). The value of DCMR for clinical decision making still needs to be defined. Hence, the purpose of this study was to assess the utility of DCMR regarding clinical management of patients with suspected and known coronary artery disease (CAD) in a routine setting.Methods and ResultsWe prospectively performed a standard DCMR examination in 1532 consecutive patients with suspected and known CAD. Patients were stratified according to the results of DCMR: DCMR-positive patients were recommended to undergo invasive coronary angiography and DCMR-negative patients received optimal medical treatment. Of 609 (40%) DCMR-positive patients coronary angiography was performed in 478 (78%) within 90 days. In 409 of these patients significant coronary stenoses ≥50% were present (positive predictive value 86%). Of 923 (60%) DCMR-negative patients 833 (90%) received optimal medical therapy. During a mean follow-up period of 2.1 ± 0.8 years (median: 2.1 years, interquartile range 1.5 to 2.7 years) 8 DCMR-negative patients (0.96%) sustained a cardiac event.In 131 DCMR-positive patients who did not undergo invasive angiography, 20 patients (15%) suffered cardiac events. In 90 DCMR-negative patients (10%) invasive angiography was performed within 2 years (range 0.01 to 2.0 years) with 56 patients having coronary stenoses ≥50%.ConclusionIn a routine setting DCMR proved a useful arbiter for clinical decision making and exhibited high utility for stratification and clinical management of patients with suspected and known CAD.
机译:背景技术最近的研究表明多巴酚丁胺应激心血管磁共振(DCMR)的诊断和预后价值始终很高。仍然需要定义DCMR在临床决策中的价值。因此,本研究旨在评估DCMR在常规情况下对可疑和已知冠状动脉疾病(CAD)患者的临床管理的实用性。方法和结果我们前瞻性对1532例连续的疑似和已知患者进行了标准DCMR检查。已知的CAD。根据DCMR的结果对患者进行分层:建议DCMR阳性的患者进行有创冠状动脉造影,而DCMR阴性的患者应接受最佳治疗。在90天内,对609名(40%)DCMR阳性患者中的478名(78%)进行了冠状动脉造影。在这些患者中的409例中,存在≥50%的显着冠状动脉狭窄(阳性预测值86%)。在923名(60%)DCMR阴性患者中,有833名(90%)获得了最佳药物治疗。在平均随访时间2.1±0.8年(中位数:2.1年,四分位间距1.5至2.7年)中,有8例DCMR阴性患者(0.96%)持续发生心脏事件.131例未进行侵入性治疗的DCMR阳性患者血管造影,有20名患者(15%)发生了心脏事件。在90例DCMR阴性的患者中(10%),在2年内(范围0.01至2.0年)进行了有创血管造影,其中56例冠状动脉狭窄≥50%的患者。实用程序,用于可疑和已知CAD患者的分层和临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号